ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS
A Maiolinoa,b, R Hajekc, T Jelinekd, P Moreaue, T Martinf, L Pourg, G Mikalah, A Symeonidisi, S Bringhenj, A Rawlingsk, ML Rissel, H Vande-Veldek, I Spickam
a Department of Internal Medicine, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
b Americas Oncologia, Rio de Janeiro, RJ, Brazil
c Department of Hemato-Oncology, University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic
d Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
e Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France
f Department of Hematology, University of California at San Francisco, San Francisco, United States
g Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
h National Institute for Hematology and Infectious Diseases, Department of Hematology and Stem Cell Transplantation, South Pest Central Hospital, Budapest, Hungary
i Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece
j Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
k Sanofi, Cambridge, United States
l Sanofi Research & Development, Vitry-sur-Seine, France
m 1st Department of Medicine – Department of Hematology, 1st Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic
Ver másRead
3057
Timeswas read the article
1127
Total PDF
1930
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 2 | 1 | 3 |
| 2025 6 | 52 | 18 | 70 |
| 2025 5 | 77 | 18 | 95 |
| 2025 4 | 55 | 12 | 67 |
| 2025 3 | 78 | 16 | 94 |
| 2025 2 | 70 | 19 | 89 |
| 2025 1 | 60 | 21 | 81 |
| 2024 12 | 56 | 13 | 69 |
| 2024 11 | 80 | 26 | 106 |
| 2024 10 | 110 | 23 | 133 |
| 2024 9 | 89 | 19 | 108 |
| 2024 8 | 76 | 24 | 100 |
| 2024 7 | 62 | 28 | 90 |
| 2024 6 | 63 | 25 | 88 |
| 2024 5 | 46 | 27 | 73 |
| 2024 4 | 54 | 21 | 75 |
| 2024 3 | 46 | 23 | 69 |
| 2024 2 | 36 | 22 | 58 |
| 2024 1 | 60 | 22 | 82 |
| 2023 12 | 45 | 21 | 66 |
| 2023 11 | 69 | 33 | 102 |
| 2023 10 | 39 | 27 | 66 |
| 2023 9 | 48 | 25 | 73 |
| 2023 8 | 35 | 23 | 58 |
| 2023 7 | 39 | 17 | 56 |
| 2023 6 | 44 | 15 | 59 |
| 2023 5 | 41 | 24 | 65 |
| 2023 4 | 21 | 20 | 41 |
| 2023 3 | 27 | 187 | 214 |
| 2023 2 | 20 | 28 | 48 |
| 2023 1 | 23 | 11 | 34 |
| 2022 12 | 31 | 12 | 43 |
| 2022 11 | 27 | 24 | 51 |
| 2022 10 | 32 | 19 | 51 |
| 2022 9 | 28 | 33 | 61 |
| 2022 8 | 17 | 19 | 36 |
| 2022 7 | 18 | 24 | 42 |
| 2022 6 | 18 | 17 | 35 |
| 2022 5 | 19 | 24 | 43 |
| 2022 4 | 22 | 26 | 48 |
| 2022 3 | 28 | 25 | 53 |
| 2022 2 | 21 | 18 | 39 |
| 2022 1 | 12 | 19 | 31 |
| 2021 12 | 16 | 18 | 34 |
| 2021 11 | 15 | 21 | 36 |
| 2021 10 | 3 | 19 | 22 |
Show all
